______

Call all oncology professionals - Be sure to reserve some time on your calendar for MSCO!

The MSCO Webinar Series: OncoInsights is an exciting evening webinar on the first Wednesday of each month. We'll include a mixture of industry partners, and CME webinars featuring a range of topics. Don't miss out on the opportunity to stay up-to-date on the latest advancements in oncology. Join us for an engaging and informative session with leading experts in the field.  

Register once, and you're on the list for the entire 2024 series!

We look forward to seeing you! 

______

July 10, 2024

Liquid Biopsy Testing Strategies for Patients With Metastatic NSCLC: A Case-Based Program

Presented in partnership with AstraZeneca

This program uses an interactive, case-based approach to educate health care providers about biomarker testing strategies, which include liquid biopsy testing to help optimize the diagnostic journey for patients with metastatic NSCLC.

Key Topics Include:

• The impact of implementing biomarker profiling on metastatic NSCLC patient care
• The benefits of integrating liquid biopsy testing with standard-of-care tissue-based testing to help support precision medicine in metastatic NSCLC
• Successes and challenges with integrating liquid biopsy testing and unique considerations for its implementation (as demonstrated in case studies)

______

August 7, 2024

Optimal Integration of TROP2-Directed ADCs Into Treatment Regimens for Patients With Non-Small-Cell Lung Cancer (NSCLC)

Presented in partnership with the Accredited Provider: Academy for Continued Healthcare Learning. Supported by educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc.

Work through complex cases to assess your capabilities to optimally implement evolving clinical practices.

Topic Highlights:

• Molecular testing recommendations in NSCLC and strategies to overcome barriers to optimize testing processes 
• Strategies for incorporating new therapies within clinical practice and for overcoming barriers to their adoption 
•  Latest clinical trial data for emerging TROP2-directed ADCs for the treatment of NSCLC 
• Multidisciplinary collaboration to enable early, appropriate treatment of patients with or without actionable markers

Speaker: Rebecca Heist, MD, MPH (Co-Chair), Associate Professor of Medicine at Harvard Medical School; Lee Albright and Nile Albright MD Endowed Chair in Clinical Cancer Research, Mass General Cancer Center, Boston, MA

CME: This activity is approved for AMA PRA Category 1 CreditsTM. Provided by the Academy for Continued Healthcare Learning (ACHL).

______

September 11, 2024

PRECISION MEDICINE: Genetics and Genomics in Cancer Care

Presented in partnership with Daiichi Sankyo Inc

The non-branded session begins with a terminology and timeline review of precision medicine and genetic variations including those that are inherited vs. acquired and those associated with carcinogenesis. Assessment techniques for genetic variations are also reviewed including IHC staining, in situ hybridization, next-generation sequencing, PCR, circulating tumor DNA, etc.

______

October 2, 2024

TBA

______

November 6, 2024

Caring for the Person in the Mirror: Managing Compassion Fatigue

Presented in partnership with Bristol Myers Squibb

Objectives:

• What is Compassion Fatigue?
• How do I manage Compassion Fatigue?
• What other resources are available to me?

______

December 4, 2024

TBA

______

Corporate member companies are eligible to submit a non-branded presentation for consideration for inclusion in a future webinar. Email msco@mms.org for more details.